

![]() |
Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial |
|
Authors | ![]() | |
Published in | JACC. Cardiovascular interventions. 2020, vol. 13, no. 19, p. 2314-2316 | |
Keywords | Absorbable Implants — Coronary Artery Disease / therapy — Drug-Eluting Stents — Everolimus — Humans — Percutaneous Coronary Intervention — Prosthesis Design — Sirolimus — Treatment Outcome | |
Identifiers | PMID: 33032722 | |
Full text | ||
Structures | ||
Citation (ISO format) | IGLESIAS, Juan Fernando et al. Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial. In: JACC. Cardiovascular interventions, 2020, vol. 13, n° 19, p. 2314-2316. doi: 10.1016/j.jcin.2020.07.038 https://archive-ouverte.unige.ch/unige:161613 |